Inve Guide

Best Stock Research Apps in India (2026): Top 10

If you own individual Indian stocks, the research app we would add first in 2026 is Inve, our own platform, and the reason is its Ambition Index: three boards (revenue, margins, capex) with one row per company, showing the target each management has set, how much of it the filed quarters have already delivered, whether the company is ahead of or behind last year's pace, and how many of its past targets it kept. That lets you compare what each management is aiming at before you decide which company to buy. Its Guidance Tracker then keeps score on each company's concall commitments — what was delivered, and where management stopped talking about a target. The other nine each win a different job: Screener.in owns ten-year ratio screens, Tijori Finance owns plant-level operating disclosures, and TradingView owns charts. Three of the ten (Inve, Screener.in and Tijori) have no iPhone app, and Screener.in and Tijori are built mainly for desktop.

Most roundups of Indian stock analysis apps compare ten versions of the same historical ratio table and stop there. That leaves out the forward-looking layer where long-term theses quietly break. In Inve's 4 September 2026 snapshot of Indian concalls, 57.8% of the 16,842 management commitments that had a later call to be judged on were achieved or still on track. More than half of that group was only on track, not yet delivered: about 3,934 commitments, or 23.4%, had actually been achieved. On track mostly means management repeated the target on a later call, which is their own grade, not a result. Another 13.5% were stated on one call and had no follow-up we could find on any later call — a figure that leans high, because a commitment counts after a single silent call, and that says nothing about management's intent. For you as a reader the consequence is simple: a target heard on one call is a claim to check on the next call, not a result.

One scope note before the rankings: we checked each vendor's pricing page, feature pages and app-store listing on 19 November 2026 — native iOS and Android apps where they exist, desktop web platforms where they do not — and judged screeners, audio players, charting tools, and AI research workflows on the same rules. The descriptions below are what each vendor publishes, not measured performance. Inve is ours and we earn when you subscribe to Pro, so we give the reasons for ranking it first in full and apply the same "where it falls short" audit to it as to the other nine. We did not compare StockInsights.ai, another concall-AI tool.

The companies and platforms discussed below illustrate an equity research workflow and are not recommendations to buy, sell, or hold any security.

What actually matters in an Indian stock research app

Think of researching a listed manufacturer the way an engineer inspects an older factory before buying it. Ten years of financial ratios are the past electricity bills, operating KPIs tell you how hard the machines are running today, a price chart tells you what neighbours offered yesterday, and a guidance ledger checks whether the new Shed B management guided for two years ago ever got built. Paying for three subscriptions that reprint the electricity bills leaves the other three questions unanswered, which is why our four-layer Indian stock research stack separates those jobs before picking tools.

Five practitioner criteria separate a durable research tool from a noisy dashboard:

  1. Primary-filing accuracy and scope discipline: Consolidated and standalone numbers must stay distinct, restatements and discontinued operations must be traceable to BSE/NSE filings, and any AI-generated figure must point back to the exact sentence or statement line it came from.
  2. Longitudinal memory across quarters: Quotes, PE multiples, and single-quarter result flashes are free commodities everywhere. Remembering what the CFO guided on margins or working capital four quarters ago — and comparing it against what actually happened — is where manual note-taking collapses across a 12-stock demat portfolio.
  3. Independence from brokerage turnover incentives: Your broker's app earns revenue or order-flow scale when you trade more often. A research app's job is frequently to talk you out of acting on a noisy headline. Each review below carries a "How it earns" line taken from the vendor's own pages; we did not audit any company's revenue.
  4. Honest mobile versus desktop reality: Commute reading — scanning a concall brief, checking promoter pledges, listening to Q&A — happens on a phone. Deep balance-sheet comparison and custom formula building still belong on a wider screen. Know which job a tool actually supports before paying an annual bill.
  5. Free-tier honesty and INR renewal math: Several Indian fintech tools advertise low monthly numbers that require annual upfront billing plus 18% GST, or lock basic exports behind a ₹5,000 tier. Start free and pay only where a tool saves hours you actually spend.

The top 10 Indian stock research apps at a glance

RankApp / PlatformBest forPricing & free tierPlatformsKey strength
1Inve (inve.money)Comparing companies' forward targets on one board (Ambition Index), concall AI & guidance trackingFree (briefs, AI screener, DCF; 50 calls + 5 ledgers/mo); Pro ₹499/mo or ₹4,799/yr (yearly billed as "2 months free")Web, Android (Google Play), Claude & Gemini MCPAmbition Index: revenue, margin & capex targets compared across companies, backed by 24,328 tracked commitments
2Screener.in10-year financial statements & custom ratio queriesGenerous free tier; Active Investor ₹4,999/yr (incl. GST)Web + Android (no iOS app)Gold-standard custom formula screening for NSE/BSE
3Tijori FinanceOperating KPIs, plant capacities & market shareLimited free latest view; ₹330/mo or ₹3,500/yrWeb + Android (no iOS app)Granular capacity, volume & raw-material disclosures
4TrendlyneMulti-factor screens, DVM matrices & alert automationFree tier; GuruQ ₹1,890/yr (list ₹2,990), StratQ ~₹5,900/yrWeb, iOS & AndroidWide alert & backtesting matrix for Indian stocks
5TickertapeClean mobile onboarding & stock/MF discoveryFree tier; Pro ₹399/mo or ₹2,999/yrWeb, iOS & AndroidApproachable mobile UX + broker portfolio sync
6TradingViewPrice charts, technical levels & multi-timeframe alertsGenerous free tier; Essential ₹995/mo billed annually (₹1,295 monthly)Web, Desktop, iOS & AndroidIn our view, the strongest charting engine across NSE, indices & commodities
7QuartrEarnings-call audio & investor-day slide decksFree iOS & Android app; web/desktop is Quartr Pro (sales-priced)Web, iOS & AndroidCall audio with searchable transcripts and slides in a free mobile app
8StockEdgeDaily NSE/BSE delivery scans & FII/DII deal trackingFree tier; Premium/Pro/Club ₹249/₹999/₹1,999 a month, or ₹1,494/₹5,994/₹11,994 a year with the current AISMART coupon (GST not stated)Web, iOS & AndroidEnd-of-day exchange scans built for mobile
9MoneycontrolLive market news, results calendar & corporate actionsAd-heavy free tier; PRO ₹499/yr on current offer (₹999 list), Super PRO ₹2,499/yr on offer (₹7,499 list), plus 18% GSTWeb, iOS & AndroidReal-time Indian market newsroom & results calendar
10KoyfinMacro series, global peers & customizable dashboardsFree (2 yrs financials); Plus $39/mo billed annually ($49 month-to-month)Web, iOS & AndroidBloomberg-style cross-market context for global sectors

Prices were checked on 19 November 2026 against each vendor's own pricing page. GST is included only where the vendor says so, and coupon or offer prices can change. Inve is ours and ranks first on our own criteria.

1. Inve — Best for Comparing Forward Targets Across Companies (Ambition Index) and Concall Guidance Tracking

Inve (web platform and Android app on Google Play) is built in Bengaluru around the step most Indian screeners leave to manual spreadsheets: turning 60-page concall transcripts and quarterly filings into a record of what management committed to, how directly executives answered analyst questions, and whether past targets were delivered, revised, or quietly dropped.

Why it is first on this list: the Ambition Index. Ratios, charts, and news are covered several times over by the other nine, and all of them describe what a company has already reported. The Ambition Index shows what companies say they will do next and how far along they are, one row per company: the revenue target, the share of it already filed, a status of Ahead, On track, or Behind, the revenue growth of the last 12 months, and how many past targets were kept. Sort it by biggest target, or by biggest stretch (the target less the growth of the last 12 months), and you can compare companies before you choose which to buy. Behind it sits the Guidance Tracker: across 1,648 Indian companies Inve tracks 24,328 management commitments, each with its quote, from the call where a target was set to the call where it was met, cut, or dropped. Nobody can do that by hand across a 10–15 stock portfolio, quarter after quarter.

The Ambition Index, board by board

BoardWhat each row showsHow you compare
RevenueSet to do: the target as a growth rate and in rupees, with its date. Done so far: how much of it the filed quarters have brought in, against the same quarters last year. Status: Ahead, On track, Behind, or Too early. Growing now: revenue growth over the last 12 months. Past targets: how many were keptSort by biggest target, biggest stretch (the target less the growth of the last 12 months), furthest ahead, or newest. Filter by status and company size
MarginsThe EBITDA margin target beside the operating margin filed so far this year, the points still to go, and a statusSort by biggest step-up still to go, or soonest deadline
CapexEach spending plan with its deadline, as a share of last year's filed revenue and a multiple of last year's capexSort by biggest for its size, or soonest deadline. One-year plans and multi-year programmes are listed apart, with no status

What it does well

  • Compare forward targets across companies (Ambition Index): The Ambition Index has three boards (revenue, margins, and capex) with one row per company; the table above shows what each board gives you. Status compares the share of the target done in the quarters filed so far with the share done in the same quarters last year, and within 3 points either way is On track. The capex board gives no status, because a large plan is not better or worse than a small one. Every target carries its transcript quote. That is the comparison that helps you choose between companies before you buy: who is aiming higher, who is already on pace, and who has kept targets before. It is a Pro feature.
  • Longitudinal guidance tracking with source quotes: Each call's brief records who said it and the quote; the Guidance Tracker then follows that target across later calls. On Infosys, for instance, you can read FY26 constant-currency revenue guidance step up across five calls (0%–3% in April 2025 → 1%–3% in July → 2%–3% in October → 3%–3.5% in January 2026 → 3.1% reported in April 2026), and then see FY27 guidance of 1.5%–3.5% (April 2026) trimmed to 1.5%–3% in July 2026 and cut to 1%–2% on the Q2 FY27 call on 23 October 2026 — the ledger records cuts as well as raises, so do not read one year's pattern as a rule — alongside graded Q&A exchanges showing where management answered directly and where it declined to quantify AI-services revenue.
  • Plain-English AI stock screener, sector boards, shareholding, and SEBI MF heatmaps — open without login: The Indian AI stock screener lets you describe a screen in plain words ("low-debt companies with ROCE ≥ 20% and positive FCF margin") and review the exact filter conditions across roughly 5,500 Indian companies on 45 FY and TTM statement ratios before applying them. Public tools also include point-in-time Indian sector earnings analysis (tracking each sector's top 20 companies by quarter-end market cap across 12 quarters), 12-quarter SEBI mutual fund category heatmaps, quarterly promoter shareholding and buy/sell filings, and an interactive DCF and Reverse DCF calculator.
  • Daily AI thesis checks (Inve Case) and native Claude/Gemini MCP: In Inve Case, you set the specific revenue, margin, debt, or guidance rules a holding must satisfy (with optional Zerodha portfolio sync), and the system checks every new NSE/BSE release and concall against your thesis daily. Power users who work inside AI assistants can connect their account directly via the Inve for Claude connector or Inve for Gemini (https://api.inve.money/mcp) so the assistant works from financials taken from filed statements and guidance parsed from calls, each with a source link. The output still needs a click-through to that source before you rely on it.
  • Transparent pricing (India pricing): Public call briefs, stock pages, the AI screener, DCF, sector boards, and shareholding require no account. A free account includes 50 full concall reads, 5 full guidance ledgers per month, and 1 saved Inve Case; Pro is ₹499/month or ₹4,799/year for the Ambition Index, the full commitment ledger, Q&A deflection history, 500 call reads, 100 guidance ledgers per month, and up to 20 tracked Inve Cases. Holding ourselves to the renewal-math rule above: the yearly plan is billed as "2 months free", and the pricing page does not say whether GST is included, so confirm it at checkout.

Where it falls short

Inve is a research platform, not a broker — you execute trades in Zerodha, Groww, Dhan, or your existing demat account. There is no native iOS App Store app yet: iPhone and iPad users read on the mobile web, and the native app is Android only. Its screener filters 45 standardized FY and TTM metrics from filed statements and does not let you write custom ten-year ratio formulas the way Screener.in does. The Indian record averages 4.18 distinct commitment birth quarters per company — one to two years, not a full business cycle — and verdicts are machine-generated, so the quote and source link beside each one are there for you to check: our parser, for example, marked Infosys's FY26 free-cash-flow conversion target as having no follow-up although the Q4 FY26 call reported it at 106% on an adjusted basis.

How it earns: Pro subscriptions. Inve is not a broker, so it takes no brokerage when you trade.

Verdict: The first tool we would add for an investor who owns individual Indian stocks: the Ambition Index compares companies on what they are aiming at, and concalls, guidance history, and daily thesis checks sit in the same place. Public briefs, the AI screener, and DCF are free with no account; Pro is ₹499/month. Pair it with Screener.in for custom ten-year ratio screens and you have both what the company reported and whether management did what it said.

See which companies are ahead of their own targets

Sort Indian companies by the size of their revenue target, or by how far ahead of last year's pace they are, with the transcript quote behind every target. The Ambition Index is part of Inve Pro.

Open the Ambition Index

2. Screener.in — Best for 10-Year Financial Ratios and Custom Queries

Screener.in built by Mittal Analytics is the foundational tool of self-directed fundamental investing in India. Its official Android app alone shows 1M+ installs on Google Play, and in our view it is the first tab most self-directed fundamental investors open on a new ticker.

What it does well

  • High signal-to-noise on historical statements, in our view: Ten-year profit-and-loss, balance-sheet, cash-flow, quarterly, peer, and shareholding tables sit together on one company page.
  • Custom ratio creation and Boolean query builder: You can define your own custom ratios (from CFO-to-EBITDA conversion to reinvestment rates), customize every column on your company screen, and set email alerts on saved screens.
  • Generous free tier: Core 10-year tables, custom ratios, 10 AI Summaries a month, and exchange PDF links are free; Active Investor runs ₹4,999/year (inclusive of GST) for result exports, commodity price trends, 55 comparison columns, unlimited AI Summaries and much higher alert limits (custom ratios are free).

Where it falls short

There is an official Android app but no iOS app, and building screens on a phone is cramped. More importantly, Screener's AI Summaries are capped at 10 a month on the free plan and its premium page still lists concalls as work in progress; it does not maintain a cross-quarter ledger showing whether the capex or working-capital days target management gave three calls ago was delivered or quietly dropped. That gap is why our guide on what to check after running a stock screener starts the moment your Screener shortlist finishes.

How it earns: The Active Investor subscription.

Verdict: Non-negotiable for first-stage Indian financial screening — even its free tier beats most paid apps on pure ratio clarity.

3. Tijori Finance — Best for Operating KPIs, Capacities and Market Share

Tijori Finance (backed by Zerodha's Rainmatter ecosystem) digs into annual reports, investor presentations, and industry filings to surface the operational building blocks that standard accounting statements compress into a single revenue line.

What it does well

  • Operational granularity: Plant capacities, capacity utilisation, revenue split by geography or product line, store counts, hospital bed additions, and raw-material cost breakdowns for Indian midcaps and largecaps.
  • Industry and market-share benchmarking: Seeing a specialty-chemical or cables maker's market share alongside input-chemical price trends saves hours of hunting through 300-page DRHPs and annual reports.
  • Fair annual pricing: Free tier shows limited recent slices; full historical access costs ₹330/month or ₹3,500/year.

Where it falls short

Tijori's Android app covers reading on the move, but there is no iOS app and the deep KPI tables still work best on a desktop. Operational KPI coverage depends on what companies voluntarily disclose in presentations, so definitions occasionally shift between quarters without warning, and forward management commitments are not systematically graded against subsequent outcomes.

How it earns: The paid plan above. It is backed by Zerodha's Rainmatter, so a broker sits among its backers.

Verdict: The sharpest operational microscope for Indian manufacturing, retail, healthcare, and cyclical businesses — use it at your desk when unit economics matter more than headline P/E.

4. Trendlyne — Best for Multi-Factor Screeners, DVM Matrices and Alerts

Trendlyne packs an enormous volume of Indian market data — Durability-Valuation-Momentum (DVM) scores, consensus broker target prices, superstar institutional portfolios, F&O heatmaps, and custom multi-parameter backtests — into web and native mobile apps.

What it does well

  • Alerting and screening breadth: High-frequency alerts across technical, fundamental, shareholding, and delivery parameters, plus Excel Connect on higher tiers.
  • Native mobile apps on iOS and Android: Easier to check watchlists, consensus broker targets, and result flashes on the move than desktop-only terminals.
  • Tiered INR plans: Usable free tier; India-focused GuruQ runs ₹1,890/year with the current coupon (list ₹2,990; ₹390 billed monthly), while power-user StratQ runs ₹5,900/year with code BESTPLAN (list ₹9,900).

Where it falls short

Interface density is high — beginners often drown in overlapping badges, composite scores, and technical widgets before finding the underlying filing truth. As with any composite score, a strong durability/valuation badge cannot warn you when management is deflecting analyst questions on receivables or when a capacity target set two years ago has stopped being mentioned on calls.

How it earns: Paid plans (GuruQ, StratQ).

Verdict: Built for data-hungry tinkerers who want granular multi-factor alerts and superstar shareholding trackers in one mobile-accessible suite.

5. Tickertape — Best Mobile Onboarding for Newer Stock & Mutual Fund Investors

Tickertape focuses on visual polish, plain-language scorecards, and smooth broker integration across web, iOS, and Android, making it the first dedicated research app many post-2020 Indian retail investors install.

What it does well

  • Beginner-friendly mobile design, in our view: Stock and mutual-fund screeners, Market Mood Index sentiment gauge, peer comparison cards, and multi-broker portfolio linking.
  • Accessible pricing: Free tier covers everyday screening and tracking; Tickertape Pro costs ₹399/month or ₹2,999/year for data exports and valuation forecasts.

Where it falls short

Analytical depth hits a ceiling quickly once you move into midcaps and smallcaps: concall coverage, footnote nuance, and segment-level operating drivers are thin, and green/red scorecard checklists can tempt newer investors into treating green ticks as due diligence.

How it earns: Pro subscriptions, and its homepage also sells "Ready-made Portfolios by smallcase", so part of the business is distributing investment products.

Verdict: A friendly mobile starting point for newer equity and mutual-fund investors — just graduate to primary transcripts and filing checks before sizing concentrated positions.

6. TradingView — Best for Charting, Technicals and Multi-Asset Price Levels

TradingView is, in our view, the charting standard in India and globally, powering both standalone technical workflows and the embedded chart engines inside major Indian discount brokers.

What it does well

  • Charting on every device: Custom Pine Script indicators, Nifty sectoral ratios, delivery volume overlays, multi-chart layouts, and server-side price alerts across web, desktop, iOS, and Android.
  • Strong free tier: One chart layout with two indicators and basic alerts costs ₹0; paid plans start from Essential at ₹995/month billed annually (₹1,295 billed monthly).

Where it falls short

Fundamental statements on TradingView are surface-level summaries, Indian concall transcripts and promoter-pledge context are not its job, and the community "Ideas" feed mixes disciplined technicians with high-conviction noise.

How it earns: Paid plans; its charts are also embedded inside Indian broker platforms.

Verdict: Essential if entry timing, stage analysis, or relative-strength charts are part of your process — strictly half a research stack, never the whole one.

7. Quartr — Best for Commute Earnings-Call Audio and Investor Decks

Quartr turns investor relations into a Spotify-like audio and slide-deck player on iOS and Android, with a paid Quartr Pro desktop/web version, covering major Indian largecaps alongside global companies.

What it does well

  • Mobile call audio: Listen to live or recorded calls while reading searchable transcripts and slides on a commute.
  • Free consumer mobile app: Core mobile audio, slides, and transcript search cost ₹0, while enterprise workflows sit in Quartr Pro on desktop.

Where it falls short

Quartr is a single-event document player, not an accountability ledger — each quarter sits in its own silo without tracking prior guidance or grading evasive Q&A, and Indian smallcap/microcap coverage trails NSE/BSE-native platforms. See our full Quartr versus Inve comparison for a deeper breakdown of document players versus guidance ledgers.

How it earns: The mobile app is free; the paid product is Quartr Pro, sold through its sales team.

Verdict: Keep it on your phone for listening to CFO tone on key holdings; pair it with a multi-quarter ledger so spoken guidance doesn't evaporate after the call ends.

8. StockEdge — Best for Daily NSE/BSE Delivery Scans and FII/DII Flows

StockEdge is purpose-built for mobile-first Indian market participants who track end-of-day exchange data: bulk and block deals, high delivery-percentage spikes, FII/DII cash and derivatives flows, and sector rotation.

What it does well

  • Mobile-native Indian exchange plumbing: Pre-built daily scans combining price action, delivery volume, and quarterly result triggers in its iOS and Android apps.
  • Clear ladder for active scanners: Useful free EOD data; Premium, Pro and Club run ₹249/₹999/₹1,999 a month, or ₹1,494/₹5,994/₹11,994 a year with the current AISMART coupon (GST not stated), with Pro and Club adding advanced chart patterns and community/analyst modules.

Where it falls short

StockEdge leans heavily toward short-to-medium-term momentum and event scanning rather than deep multi-year balance-sheet auditing, accounting red-flag work, or cross-quarter management credibility.

How it earns: Paid plans (Premium, Pro, Club).

Verdict: Strong for active swing investors monitoring NSE/BSE delivery and institutional deal flow — overkill on the upper tiers if you buy and hold for five years.

9. Moneycontrol — Best for Real-Time Indian Market News and Corporate Actions

Moneycontrol is, in our view, India's default market town square for live NSE/BSE quotes, earnings dates, board-meeting alerts, IPO trackers, and macro/policy reporting on web, iOS, and Android.

What it does well

  • Ubiquity and speed on Indian headlines: Fast coverage of SEBI circulars, RBI policy, block-deal tape reports, and quarterly result flashes.
  • Inexpensive paid tiers: Moneycontrol PRO costs ₹499/year on the current offer (list ₹999, plus 18% GST), with Super PRO at ₹2,499/year + GST on offer (list ₹7,499); a separate Ad Lite plan (₹199/yr launch offer, list ₹599) advertises about 80% fewer ads.

Where it falls short

The free app carries heavy advertising, lending cross-sells, and noisy forum threads ("MC Message Board" should never be confused with research), and its fundamental tables lack customizability and primary-quote traceability.

How it earns: Advertising and lending cross-sells on the free product, plus PRO subscriptions.

Verdict: Useful as a clean ₹499/year (+GST) news wire and corporate-actions calendar — do your actual valuation and management verification elsewhere.

10. Koyfin — Best for Global Macro Dashboards and Cross-Border Peer Context

Koyfin brings a customizable, Bloomberg-inspired terminal to web, iOS, and Android, covering global stocks, bond yields, FX, commodities, and Capital IQ consensus estimates.

What it does well

  • Cross-asset context: Ideal when you are analysing Indian IT services, pharma, metals, or specialty-chemical exporters against US/European customers, global Dollar Index moves, or 10-year Treasury yields.
  • Web + mobile sync: Watchlists, valuation scatter plots, and macro charts are offered across desktop and native mobile apps.

Where it falls short

Dollar pricing (Plus at $39/month billed annually, or $49 month-to-month) is steep if you invest solely in domestic Indian equities, the free tier caps financial history at two years, and India-specific nuances — promoter pledging, SEBI mutual-fund category flows, and concall commitment tracking — require Indian-native tools.

How it earns: Paid plans priced in dollars.

Verdict: The best bridge terminal if you actively compare Indian exporters against global peers or run a split India-plus-US portfolio (for dedicated US coverage, see the US edition of our best stock research apps guide).

Which app combination fits your budget and workflow?

Instead of hoarding five overlapping annual subscriptions, pair one historical ratio tool with one forward-evidence / call accountability tool:

Investor profileRecommended stackCombined costWhy these don't overlap
Zero-rupee fundamentalistScreener.in (Free) + Inve (Free account) + Quartr (Free)₹010-year NSE/BSE statements + AI screener, public concall briefs, 50 call reads & 5 guidance ledgers/mo + mobile call audio
Serious part-time owner (10–20 stocks)Screener.in (Free) + Inve Pro₹499/mo (or ₹4,799/yr)Screener handles initial ratio filtering; Inve Pro tracks the targets our parser extracts, Q&A dodges, and daily Inve Case checks across up to 20 holdings
Deep industrial / midcap specialistScreener.in Active (₹4,999/yr) + Tijori (₹3,500/yr) + Inve Pro (₹4,799/yr)~₹1,108/mo effectiveDownloads, peer comparison & commodity price trends + plant-level capacity/market-share data + longitudinal concall commitment audit
Techno-fundamental swing / position investorTradingView Essential + Screener.in (Free) + Inve (Free or Pro)From ₹995/mo (Essential billed annually; ₹1,295 billed monthly)Multi-timeframe chart levels & alerts paired with fundamental cash-conversion checks and concall red-flag screening

There is also a path that needs no app at all: transcripts are free on BSE/NSE and on company investor-relations pages. For a 10-stock portfolio that is about 40 transcripts a year plus a spreadsheet. It beats paying when you hold few stocks and have the discipline to take notes every quarter; it breaks down in results season, or once you hold 15 or more.

Audit what management guided before you trust the ratio screen

Read structured concall briefs, graded Q&A exchanges, and multi-quarter guidance histories across 1,650+ listed Indian companies — on web, Android, or Claude & Gemini MCP.

Explore Indian concall briefs

How Inve fits alongside Screener.in, Tijori, and your broker

You do not need to abandon Screener.in or your charting setup to add longitudinal call verification. A clean 30-minute workflow per company uses each tool strictly where its evidence is strongest:

  1. Filter the universe on filed accounts: Run your first-pass screen in Screener.in or Inve's plain-English AI stock screener to eliminate structurally weak balance sheets and poor cash conversion.
  2. Separate company skill from sector tailwinds: Check the point-in-time sector earnings board to verify whether a company's margin jump beat its top-20 sector peers or merely rode an industry cycle.
  3. Audit management's spoken track record: Open Concall AI for the latest quarter's extracted guidance and graded Q&A, then check the Guidance Tracker using our guidance-verification checklist to see whether prior working-capital, capex, or margin targets were achieved, revised down, or went quiet (remembering that 25.4% of the 279 eligible working-capital commitments we track and 19.6% of the 750 eligible capex commitments we track had no parsed call follow-up — the counts are lower bounds because categories are matched on free text, and the shares lean high because a commitment becomes eligible after a single silent call).
  4. Cross-check ownership, valuation, and automate monitoring: Verify promoter shareholding disclosures and institutional moves, test implied growth expectations in the DCF calculator, and lock your falsifiable thesis conditions into an Inve Case so future filings are checked automatically while your broker app stays closed until you actually have a decision to execute.

Where app rankings and AI research tools can mislead you

The strongest argument against relying on any research app — including Inve — is that better software creates the illusion of deeper conviction without removing business uncertainty. A management team running a mediocre, capital-hungry business can set conservative annual guidance every May, step neatly over it four quarters in a row, and look pristine inside a guidance tracker while destroying shareholder value through poor capital allocation. Conversely, an honest industrial promoter navigating a customer capex delay may cut guidance early, log a missed or revised_down row, and still compound Intrinsic Value brilliantly over seven years.

Three specific data boundaries also govern Inve's Indian corpus figures cited above:

  • Short time depth: The 4 September 2026 snapshot averaged 4.18 distinct commitment birth quarters per company — enough to observe one annual guidance cycle, nowhere near enough to judge management integrity across a full credit cycle.
  • Concalls are not the whole disclosure record: A ghosted classification means our parser found no follow-up on a subsequent earnings call in the corpus. Companies sometimes close out a target inside an annual report footnote, press release, or investor presentation table, or the parser itself can miss a spoken update (as in the Infosys FY26 cash-conversion example). The label also says nothing about management's intent. Always click through to the source PDF before acting.
  • Model-extraction variance: The Indian commitment dataset was built across two model runs (gemini-2.5-pro across 1,469 company runs and gemini-3.1-pro-preview across 179 company runs) without a shared holdout set, and Q&A deflection streaks (609 persistent dodges across 452 companies) are medium-confidence model classifications rather than statutory audit findings.

Keep your trading app and your research stack separate, start on the free tiers, and pay only for the layer of evidence you actually fail to maintain by hand. Before adding another subscription, ask one owner's question: if management quietly stopped mentioning the single target my thesis depends on two quarters from now, which tab on my phone would tell me?

Frequently asked questions

What is the best stock research app in India in 2026?

For an investor who owns individual stocks, our pick is Inve, our own platform (inve.money, on web, Android Google Play, and Claude/Gemini MCP): it compares companies' forward revenue, margin, and capex targets on the Ambition Index, and covers concall summaries, multi-quarter management guidance tracking, and automated daily thesis checks, the forward-looking layer most tools reviewed here leave open (we did not compare StockInsights.ai). Pair it with Screener.in for 10-year custom ratio screens, Tijori Finance for plant and market-share disclosures, or TradingView for technical charting.

Which is the best free stock analysis tool in India?

A ₹0 stack of Screener.in's free tier (10-year financial statements and ratio filters), Inve's free tier (public concall briefs, 45-metric plain-English AI stock screener, sector earnings boards, SEBI mutual-fund heatmaps, DCF calculator, plus 50 full call reads and 5 guidance ledgers per month on a free account), and Quartr's free mobile app (earnings-call audio and slides) covers ratios, guidance history and call audio without a subscription.

Do Screener.in and Tijori Finance have mobile apps?

Partly — Screener.in and Tijori Finance both have official Android apps but no iOS app (beware of unrelated lookalike apps). Inve offers a native Android app on Google Play alongside its mobile-responsive web app (with no native iOS app yet), while Trendlyne, Tickertape, TradingView, Quartr, StockEdge, Moneycontrol, and Koyfin offer both iOS and Android apps.

What is the Inve Ambition Index?

It is three boards (revenue, margins, and capex) that compare Indian companies' own forward targets, one row per company. A revenue row shows the target as a growth rate and in rupees with its date, how much of it the filed quarters have already brought in, a status of Ahead, On track, or Behind last year's pace, the revenue growth of the last 12 months, and how many of the company's past targets were kept. You can sort by biggest target, biggest stretch, or furthest ahead. It does not predict whether a company will reach its target. It is part of Inve Pro (₹499/month or ₹4,799/year).

How is Inve different from Screener.in, Trendlyne, or Tickertape?

Screener.in, Trendlyne, and Tickertape focus primarily on historical financial statements, valuation ratios, technical/delivery scans, and single-quarter summaries. Inve focuses on cross-quarter management accountability and primary-source verification: it extracts forward commitments across 1,648 Indian companies (each call's brief records who said it and the quote), tracks whether targets were delivered, revised, or left unmentioned (ghosted), grades analyst Q&A responses, and connects directly to Claude and Gemini via MCP.

Are paid stock research subscriptions worth ₹3,000–₹5,000 a year in India?

Only when you hit a concrete friction wall on the free tier, or on the do-it-yourself path of free BSE/NSE transcripts and a spreadsheet. Upgrade to Screener Active Investor (₹4,999/year) if you need exports, commodity trends or wide multi-column peer comparisons, Tijori (₹3,500/year) if you research capacity-driven midcaps full-time, or Inve Pro (₹499/month or ₹4,799/year) when manually tracking quarterly concall guidance and thesis conditions across 10–20 holdings breaks down during results season.

Why shouldn't I just use my broker app (Zerodha Kite, Groww, Upstox, or Angel One) for stock research?

Brokerage apps are engineered for fast order execution, margin visibility, and clean portfolio accounting — jobs they do well. Their business model rewards transaction activity, and their embedded research widgets usually stop at surface ratios and news headlines. Keeping your research environment separate from your "Buy/Sell" button reduces impulse trades during volatile results days.

Inve is a research and analysis platform, not an investment adviser. Nothing here is a recommendation to buy or sell any security. Do your own research or consult a SEBI-registered adviser before investing.

Free Research & Alerts

Track what Indian management promised vs. delivered — Free

Free account includes 50 concall reads and 5 full guidance ledgers a month, plus same-day transcript verdict alerts. No password, no spam calls.